Literature DB >> 29935844

Real-World Pseudoprogression: an Uncommon Phenomenon.

Karen L Reckamp1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29935844     DOI： 10.1016/j.jtho.2018.05.011

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  4 in total

1.  Pseudoprogression during Immunotherapy in Metastatic Head and Neck Squamous Cell Carcinoma.

Authors:  Akshay Bedmutha; Ashish Kaushal
Journal:  Radiol Imaging Cancer       Date:  2022-05

2.  Unsatisfied Reporting Quality of Clinical Trials Evaluating Immune Checkpoint Inhibitor Therapy in Cancer.

Authors:  Chen Chen; Yixin Zhou; Xuanye Zhang; Yuhong Wang; Li-Na He; Zuan Lin; Tao Chen; Yongluo Jiang; Shaodong Hong; Li Zhang
Journal:  Front Immunol       Date:  2021-10-05       Impact factor: 7.561

Review 3.  Role of liquid biopsy for thoracic cancers immunotherapy.

Authors:  Raimondo Di Liello; Flora Cimmino; Soraya Simón; Emilio Francesco Giunta; Vincenzo De Falco; Paloma Martín-Martorell
Journal:  Explor Target Antitumor Ther       Date:  2020-06-29

4.  The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy.

Authors:  Wenxiao Jia; Qianqian Gao; Anqin Han; Hui Zhu; Jinming Yu
Journal:  Cancer Biol Med       Date:  2019-11       Impact factor: 4.248
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.